Related Experiment Video
Updated: May 31, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Immunotherapy in Recurrent Ovarian Cancer
Keyao Chen1, Jingjing Wang1, Meng Yang1
1Gynecology Department, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.
Immunotherapy shows promise for recurrent ovarian cancer, offering new hope beyond traditional treatments. Combinations of therapies and biomarkers are key to improving patient outcomes and personalizing treatment strategies.
Area of Science:
- Oncology
- Immunology
- Cancer Therapeutics
Background:
- Recurrent ovarian cancer poses treatment challenges due to limited efficacy of chemotherapy and surgery.
- Immunotherapy presents a novel strategy by modulating the immune response against ovarian tumors.
Purpose of the Study:
- To review advances in immunotherapy for recurrent ovarian cancer.
- To discuss efficacy, mechanisms, and predictive biomarkers of these novel treatments.
Main Methods:
- Systematic review of immunotherapy modalities including immune checkpoint inhibitors, combination therapies, vaccines, and cell therapies.
- Assessment of biomarkers for predicting immunotherapy response in ovarian cancer.
Main Results:
- Immunotherapy, especially combination approaches, shows promising efficacy in recurrent ovarian cancer.
- Distinct immune microenvironments exist in platinum-sensitive versus -resistant ovarian cancer, impacting treatment.
- Potential biomarkers identified may aid in patient stratification and treatment optimization.
Conclusions:
- Immunotherapy, particularly combination strategies, offers significant advancements for recurrent ovarian cancer.
- Further research into predictive biomarkers and immune microenvironment is essential for personalized treatment.
More Related Videos
07:59Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...